-
1
-
-
0030613643
-
GABA(A), NMDA and AMPA receptors: A developmentally regulated 'menage a trois'
-
DOI 10.1016/S0166-2236(97)01147-8, PII S0166223697011478
-
Ben-Ari Y., Khazipov R., Leinekugel X., Caillard O., Gaiarsa J.L.: GABA-A, NMDA and AMPA receptors: a developmentally regulated "menage a trois". Trends Neurosci., 1997; 20: 523-529. (Pubitemid 27459658)
-
(1997)
Trends in Neurosciences
, vol.20
, Issue.11
, pp. 523-529
-
-
Ben-Ari, Y.1
Khazipov, R.2
Leinekugel, X.3
Caillard, O.4
Gaiarsa, J.-L.5
-
2
-
-
0031136772
-
Localization of NMDA receptors in the cerebral cortex: A schematic overview
-
Conti F.: Localization of NMDA receptors in the cerebral cortex: a schematic overview. Braz. J. Med. Biol. Res., 1997; 30: 555-560. (Pubitemid 127521173)
-
(1997)
Brazilian Journal of Medical and Biological Research
, vol.30
, Issue.5
, pp. 555-560
-
-
Conti, F.1
-
3
-
-
0035369112
-
NMDA receptor subunits: Diversity, development and disease
-
DOI 10.1016/S0959-4388(00)00215-4
-
Cull-Candy S., Brickley S., Farrant M.: NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol., 2001; 11: 327-335. (Pubitemid 32524098)
-
(2001)
Current Opinion in Neurobiology
, vol.11
, Issue.3
, pp. 327-335
-
-
Cull-Candy, S.1
Brickley, S.2
Farrant, M.3
-
4
-
-
33947607998
-
The clinical role of NMDA receptor antagonists for the treatment of postoperative pain
-
DOI 10.1016/j.bpa.2006.12.006, PII S1521689606000875
-
De Kock M.F., Lavand'homme P.M.: The clinical role of NMDA receptor antagonists for the treatment of postoperative pain. Best Pract. Res. Clin. Anaesthesiol., 2007; 21: 85-98. (Pubitemid 46478028)
-
(2007)
Best Practice and Research in Clinical Anaesthesiology
, vol.21
, Issue.1
, pp. 85-98
-
-
De Kock, M.F.1
Lavand'homme, P.M.2
-
5
-
-
58149463218
-
Surface trafficking of N-methyl-D-aspartate receptors: Physiological and pathological perspectives
-
Groc L, Bard L., Choquet D.: Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience, 2009; 158: 4-18.
-
(2009)
Neuroscience
, vol.158
, pp. 4-18
-
-
Groc, L.1
Bard, L.2
Choquet, D.3
-
6
-
-
33748920372
-
AMPA and NMDA glutamate receptor trafficking: Multiple roads for reaching and leaving the synapse
-
DOI 10.1007/s00441-006-0254-9
-
Groc L., Choquet D.: AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse. Cell Tissue Res., 2006; 326: 423-438. (Pubitemid 44435818)
-
(2006)
Cell and Tissue Research
, vol.326
, Issue.2
, pp. 423-438
-
-
Groc, L.1
Choquet, D.2
-
7
-
-
34247146773
-
NMDA neurotransmission as a critical mediator of borderline personality disorder
-
Grosjean B., Tsai G.E.: NMDA neurotransmission as a critical mediator of borderline personality disorder. J. Psychiatry Neurosci., 2007; 32: 103-115. (Pubitemid 46597956)
-
(2007)
Journal of Psychiatry and Neuroscience
, vol.32
, Issue.2
, pp. 103-115
-
-
Grosjean, B.1
Tsai, G.E.2
-
8
-
-
67349252254
-
The acute effects of NMDA antagonism: From the rodent to the human brain
-
Gunduz-Bruce H.: The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res. Rev., 2009, 60: 279-286.
-
(2009)
Brain Res. Rev.
, vol.60
, pp. 279-286
-
-
Gunduz-Bruce, H.1
-
9
-
-
29044449313
-
N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: A revolving neurochemical axis for therapeutic intervention?
-
DOI 10.1016/j.pneurobio.2005.10.008, PII S0301008205001528
-
Haddad J.J.: N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog. Neurobiol., 2005; 77: 252-282. (Pubitemid 41790443)
-
(2005)
Progress in Neurobiology
, vol.77
, Issue.4
, pp. 252-282
-
-
Haddad, J.J.1
-
10
-
-
2542431131
-
Rationale for and use of NMDA receptor antagonists in Parkinson's disease
-
DOI 10.1016/j.pharmthera.2004.04.001, PII S016372580400049X
-
Hallett P.J., Standaert D.G.: Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol. Ther., 2004; 102: 155-174. (Pubitemid 38681014)
-
(2004)
Pharmacology and Therapeutics
, vol.102
, Issue.2
, pp. 155-174
-
-
Hallett, P.J.1
Standaert, D.G.2
-
11
-
-
1842483228
-
The rise and fall of NMDA antagonists for ischemic stroke
-
DOI 10.2174/1566524043479248
-
Hoyte L., Barber P.A., Buchan A.M., Hill M.D.: The rise and fall of NMDA antagonists for ischemic stroke. Curr. Mol. Med., 2004; 4: 131-136. (Pubitemid 38425910)
-
(2004)
Current Molecular Medicine
, vol.4
, Issue.2
, pp. 131-136
-
-
Hoyte, L.1
Barber, P.A.2
Buchan, A.M.3
Hill, M.D.4
-
12
-
-
46849097142
-
NMDA receptors in clinical neurology: excitatory times ahead
-
DOI 10.1016/S1474-4422(08)70165-0, PII S1474442208701650
-
Kalia L.V., Kalia S.K., Salter M.W.: NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol., 2008; 7: 742-755. (Pubitemid 351957932)
-
(2008)
The Lancet Neurology
, vol.7
, Issue.8
, pp. 742-755
-
-
Kalia, L.V.1
Kalia, S.K.2
Salter, M.W.3
-
13
-
-
0036830627
-
NMDA receptor pathways as drug targets
-
DOI 10.1038/nn936
-
Kemp J.A., McKernan R.M.: NMDA receptor pathways as drug targets. Nature Neurosci., 2002; 5 Suppl.: 1039-1042. (Pubitemid 35247194)
-
(2002)
Nature Neuroscience
, vol.5
, Issue.SUPPL.
, pp. 1039-1042
-
-
Kemp, J.A.1
McKernan, R.M.2
-
14
-
-
33846981870
-
NMDA receptors and schizophrenia
-
Kristiansen L.V., Huerta I., Beneyto M., Meador-Woodruff J.H.: NMDA receptors and schizophrenia. Curr. Opin. Pharmacol., 2007; 7: 48-55.
-
(2007)
Curr. Opin. Pharmacol.
, vol.7
, pp. 48-55
-
-
Kristiansen, L.V.1
Huerta, I.2
Beneyto, M.3
Meador-Woodruff, J.H.4
-
15
-
-
0033190699
-
NMDA agonists and as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders
-
Krystal J.H., D'Souza D.C., Petrakis I.L., Belger A., Berman R.M., Charney D.S., Abi-Saab W., Madonick S.: NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Har. Rev. Psychiatry, 1999; 7: 125-143. (Pubitemid 30240826)
-
(1999)
Harvard Review of Psychiatry
, vol.7
, Issue.3
, pp. 125-143
-
-
Krystal, J.H.1
D'Souza, D.C.2
Petrakis, I.L.3
Belger, A.4
Berman, R.M.5
Charney, D.S.6
Abi-Saab, W.7
Madonick, S.8
-
16
-
-
34249099711
-
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
-
DOI 10.1038/nrn2153, PII NRN2153
-
Lau C.G., Zukin R.S.: NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci., 2007, 8: 413-426. (Pubitemid 46789232)
-
(2007)
Nature Reviews Neuroscience
, vol.8
, Issue.6
, pp. 413-426
-
-
Lau, C.G.1
Zukin, R.S.2
-
17
-
-
34249093924
-
Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
-
DOI 10.2174/138945007780618472
-
Lipton S.A.: Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr. Drug Targets, 2007, 8: 621-632. (Pubitemid 46785060)
-
(2007)
Current Drug Targets
, vol.8
, Issue.5
, pp. 621-632
-
-
Lipton, S.A.1
-
18
-
-
17744399498
-
N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: Novel insights and clinical perspectives
-
DOI 10.1007/s00213-005-2199-1
-
Millan M.J.: N-methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology, 2005; 179: 30-53. (Pubitemid 40576691)
-
(2005)
Psychopharmacology
, vol.179
, Issue.1
, pp. 30-53
-
-
Millan, M.J.1
-
19
-
-
30844439634
-
Glutamate-based therapeutic approaches: Clinical trials with NMDA antagonists
-
DOI 10.1016/j.coph.2005.12.002, PII S1471489205001785
-
Muir K.W.: Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol., 2006; 6: 53-60. (Pubitemid 43103819)
-
(2006)
Current Opinion in Pharmacology
, vol.6
, Issue.1 SPEC. ISS.
, pp. 53-60
-
-
Muir, K.W.1
-
20
-
-
0035179658
-
NMDA Receptor regulation of memory and behavior in humans
-
DOI 10.1002/hipo.1069
-
Newcomer J.W., Krystal J.H.: NMDA receptor regulation of memory and behaviour in humans. Hippocampus, 2001; 11: 529-542. (Pubitemid 33100374)
-
(2001)
Hippocampus
, vol.11
, Issue.5
, pp. 529-542
-
-
Newcomer, J.W.1
Krystal, J.H.2
-
21
-
-
0014937190
-
Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine
-
Olney J.W., Ho O.L.: Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature, 1970; 227: 609-611.
-
(1970)
Nature
, vol.227
, pp. 609-611
-
-
Olney, J.W.1
Ho, O.L.2
-
22
-
-
33846920665
-
NMDA receptor subunits: function and pharmacology
-
DOI 10.1016/j.coph.2006.08.011, PII S1471489206001883, Neurosciences
-
Paoletti P., Neyton J.: NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol., 2007; 7: 39-47. (Pubitemid 46238036)
-
(2007)
Current Opinion in Pharmacology
, vol.7
, Issue.1
, pp. 39-47
-
-
Paoletti, P.1
Neyton, J.2
-
23
-
-
0141458065
-
The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review
-
Petrenko A.B., Yamakura T., Baba H., Shimoji K.: The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth. Analg., 2003; 97: 1108-1116. (Pubitemid 37158698)
-
(2003)
Anesthesia and Analgesia
, vol.97
, Issue.4
, pp. 1108-1116
-
-
Petrenko, A.B.1
Yamakura, T.2
Baba, H.3
Shimoji, K.4
-
24
-
-
24744440576
-
Mechanism-based targeting of NMDA receptor functions
-
DOI 10.1007/s00018-005-5227-8
-
Popescu G.: Mechanism-based targeting of NMDA receptor functions. Cell Mol. Life Sci., 2005; 62: 2100-2111. (Pubitemid 41291666)
-
(2005)
Cellular and Molecular Life Sciences
, vol.62
, Issue.18
, pp. 2100-2111
-
-
Popescu, G.1
-
25
-
-
34249085665
-
NMDA and AMPA receptors: old channels, new tricks
-
DOI 10.1016/j.tins.2007.03.012, PII S016622360700077X
-
Rao V.R., Finkbeiner S.: NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci., 2007; 30: 284-291. (Pubitemid 46802833)
-
(2007)
Trends in Neurosciences
, vol.30
, Issue.6
, pp. 284-291
-
-
Rao, V.R.1
Finkbeiner, S.2
-
26
-
-
0029558275
-
NMDA antagonists: Antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles
-
DOI 10.1016/S1043-6618(95)80002-6
-
Sagratella S.: NMDA antagonists: antiepileptic neuroprotective drugs with diversified neuropharmacological profiles. Pharmacol. Res., 1995; 32: 1-13. (Pubitemid 26003791)
-
(1995)
Pharmacological Research
, vol.32
, Issue.1-2
, pp. 1-13
-
-
Sagratella, S.1
-
27
-
-
42949104029
-
Assembly and forward trafficking of NMDA receptors (Review)
-
DOI 10.1080/09687680801971367, PII 791508052
-
Stephenson F.A., Cousins S.L., Kenny A.V.: Assembly and forward trafficking of NMDA receptors. Mol. Membr. Biol., 2008; 25: 311-320. (Pubitemid 351620416)
-
(2008)
Molecular Membrane Biology
, vol.25
, Issue.4
, pp. 311-320
-
-
Stephenson, F.A.1
Cousins, S.L.2
Kenny, A.V.3
-
28
-
-
70349122557
-
Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management
-
Suzuki M.: Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management. Curr. Opin. Anaesthesiol., 2009; 22: 618-622.
-
(2009)
Curr. Opin. Anaesthesiol.
, vol.22
, pp. 618-622
-
-
Suzuki, M.1
|